Across TCGA pan-cancer cohorts, RIMBP3C Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RIMBP3C data layer compared with 21 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RIMBP3C Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RIMBP3C expression acts as an unfavorable survival marker.

UCEC and LIHC are the cancer types where RIMBP3C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.231	0.873	<.001	36	view →
LIHC	OS	Median	All	0.144	0.688	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RIMBP3C tumor-vs-normal RNA expression · all RIMBP3C data types